Monsanto Company
 (MON)

- NYSE
What's your position on ?
Bullish
Bearish
Why are you ish?
Skip
Post
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Last vote:
  • Jan. 6, 2014, 10:07 AM
    • Monsanto (MON +0.1%) is enjoying some analyst love ahead of its Jan. 8 earnings report, as Susquehanna's Don Carson raises his target price on the shares to $145 from $128 and Morgan Stanley lifts its target to a Street-high $150 on "positive seed dynamics" with a bull case target of $200/share.
    • Carson expects MON to raise its FY 2014 guidance.
    | Jan. 6, 2014, 10:07 AM | 1 Comment
  • Jan. 3, 2014, 5:48 PM
    • The USDA says it is leaning towards approval of Dow AgroSciences' (DOW) genetically modified Enlist corn and soybeans that have been heavily criticized by groups who say they will harm the environment.
    • The Enlist seeds are designed to be used in combination with a new herbicide developed by DOW that combines the weed-killers 2,4-D, known for its use in the Agent Orange defoliant, and glyphosate.
    • DOW says the crops and the herbicide combination will help combat an explosion of crop-choking weeds around the U.S. that have become resistant to glyphosate, the chief ingredient in the Roundup herbicide sold by rival Monsanto (MON).
    | Jan. 3, 2014, 5:48 PM | 6 Comments
  • Jan. 3, 2014, 4:02 AM
    • General Mills (GIS) has stopped using genetically modified ingredients in Cheerios, saying that it would label the packaging of the breakfast cereal accordingly.
    • It's a rare move from General Mills, as food companies have been wary of GM labeling because they fear it would cause consumers to think that such foods are dangerous.
    • Indeed, General Mills went out of its way to say that the Cheerios change had nothing to do with safety or pressure from anti-GM activists. Tellingly, though, the company said that the alteration was due to demand from customers - who presumably are concerned about safety.
    • The question now is whether other food companies will follow suit and what the long-term effect on GM companies such as Monsanto (MON) might be.
    • General Mills blog post.
    | Jan. 3, 2014, 4:02 AM | 6 Comments
  • Dec. 30, 2013, 10:59 AM
    • Piper is out reiterating an Overweight rating on shares of Monsanto (MON +0.3%).
    • Price target is $135.
    • Analyst Michael Cox's checks indicate a positive order book for the fall.
    | Dec. 30, 2013, 10:59 AM
  • Dec. 11, 2013, 10:29 AM
    • Monsanto (MON) is teaming up with a Danish biotech Novozymes (NVZMF, NVZMY) to develop microscopic organisms that help plants grow and resist pests, a move that could enable it to circumvent some concerns over its genetically modified seeds.
    • MON will pay $300M as part of the deal, in which the companies plan to combine their efforts to cultivate beneficial bacteria; they will split the cost of development equally and each get 50% of the profits from sales.
    • The idea of using microbes for plants hasn't caught on yet in part because many of the largest farmers are used to growing crops with synthetic fertilizer, scientists say.
    | Dec. 11, 2013, 10:29 AM | 1 Comment
  • Dec. 9, 2013, 4:39 PM
    • Monsanto Company (MON) declares $0.43/share quarterly dividend, in line with previous.
    • Forward yield 1.54%
    • Payable Jan 31; for shareholders of record Jan 10; ex-div Jan 8.
    | Dec. 9, 2013, 4:39 PM
  • Nov. 18, 2013, 1:59 PM
    • China reportedly rejected a cargo of U.S. corn because it contained a genetically modified variety not approved for import; the shipment was said to contain Syngenta's (SYT -0.4%) Agrisure Viptera corn.
    • Earlier this year, Monsanto (MON) ran into trouble when an unapproved GMO strain of wheat it had devloped showed up in a farmer's field in Oregon.
    | Nov. 18, 2013, 1:59 PM
  • Nov. 11, 2013, 3:40 PM
    • Monsanto (MON -0.6%) is reiterated with a Buy rating at UBS, which also raises its price target to $118 from $110, following what the firm calls a "very upbeat" biennial investor event.
    • Given MON's confidence in near 8% gross profit growth from mix alone this year despite lower crop prices, the firm says it has greater confidence in modelling the same growth rate for next year; only 25% of soybeans in the Americas have MON's Gen 2 Roundup tolerance trait, and Latin American insect protected soy also set to ramp sharply in the next few years.
    • MON's new platforms could ramp to ~$1B in sales by 2018-19, the firm adds.
    | Nov. 11, 2013, 3:40 PM | 1 Comment
  • Nov. 8, 2013, 7:59 AM
    • DuPont's (DD) agricultural seed unit of DuPont is teaming with Deere (DE) in a race against rival Monsanto (MON) to provide farmers with enhanced "precision agriculture" analyses aimed at maximizing crop production.
    • The programs, which will roll out next year, will give farmers guidance on field management decisions including planting, crop treatment, pest control and even the best time to harvest.
    • DuPont Pioneer has long counseled farmers on the best seed to plant for their particular farms, but the deal with Deere is the latest in a series of moves by both DD and rival MON to turn farm-related data analyses into new profit streams by incorporating analytics on an array of data points.
    | Nov. 8, 2013, 7:59 AM | 8 Comments
  • Nov. 5, 2013, 7:54 AM
    • Monsanto (MON+2.2% premarket after announcing a $1B public debt offering, with $400M in three-year bonds, $300M in five-year bonds and $300M in 30-year bonds.
    • MON intends to use the net proceeds, together with available cash, to repay debt issued to finance the acquisition of The Climate Corp. and for other general corporate purposes.
    | Nov. 5, 2013, 7:54 AM
  • Oct. 4, 2013, 3:35 PM
    • Dow Chemical (DOW +2.8%) reveals plans to challenge Monsanto’s (MON +0.2%) insect-repelling soybeans for South America with beans engineered to kill pests with two added genes.
    • MON estimates the market for its Intacta beans, which are being introduced on 3M acres this year and have one Bt gene to control bugs, at 100M acres; Dow says having two Bt genes with different modes of action will slow insects’ ability to overcome the technology.
    • Dow says the new soybeans should be available in Brazil and Argentina in three to five years, pending regulatory approvals.
    | Oct. 4, 2013, 3:35 PM | 1 Comment
  • Oct. 3, 2013, 11:49 AM
    • Monsanto (MON -0.3%) is pulled from the Conviction Buy list at Goldman Sachs after its dilutive acquisition of Climate Corporation, as MON believes the deal will be $0.14 dilutive to 2014 EPS.
    • The firm still rates MON a Buy but with a reduced price target of $118, down from $124, and lowers its FY 2014 EPS from $5.54 to $5.46 to account for the company's weaker than expected 2013 base, not yet including the acquisition.
    • Deutsche Bank lifts its price target to $120 from $116, however, as the Climate Corp. acquisition leaves MON "well positioned to address agriculture's next major growth frontier: the use of data to optimize farmer decision making and drive incremental yield."
    | Oct. 3, 2013, 11:49 AM | 1 Comment
  • Oct. 2, 2013, 3:49 PM
    • Investors appear unimpressed with Monsanto's (MON -1.4%) $930M purchase of Climate Corp. and instead focus on MON's 2014 profit forecast and a drop in gross profit in its key corn and soybean seed business in the latest quarter.
    • "Seed gross profit was down more than expected," and the 2014 outlook is too low, BGC Financial says.
    • MON is positioning the Climate Corp. acquisition as part of a longer-term recovery plan, and a tip of the hat to bigger issues around ecology; "The weather is becoming more extreme. We found that we had kindred spirits with the folks at Monsanto," says Climate Corp's COO.
    • In the earnings conference call, CEO Hugh Grant called the deal a transformational event: "This is the entry ticket into a $20B market opportunity" for data-driven products to help farmers boost production. "It will strengthen our growth rate over the coming decade."
    | Oct. 2, 2013, 3:49 PM
  • Oct. 2, 2013, 8:40 AM
    • More on Monsanto's (MON) FQ4 results: Net sales rose 5% Y/Y to $2.2B from $2.1B, while total operating expenses increased to $1.21B from $1.14B.
    • For FY 2013, Seeds and Genomics segment sales totaled $10.3B, led by its global corn portfolio that gained 13% Y/Y; segment sales in FQ4 were ~$1.2B; the segment is expected to be the biggest driver of growth, with expectations to mid-teens gross profit growth in FY 2014.
    • Plans to pay $930M to acquire the Climate Corporation, which it describes as a leader in agriculture analytics and risk management.
    • Sees FY 2014 EPS of $5.00-$5.20 after $0.14 in acquisition-related dilution; analysts had been expecting $5.33.
    • Shares -2.1% premarket.
    | Oct. 2, 2013, 8:40 AM | 5 Comments
  • Oct. 2, 2013, 8:03 AM
    • Monsanto (MON): FQ4 EPS of -$0.47 misses by $0.04.
    • Revenue of $2.20B misses by $0.04B. (PR)
    | Oct. 2, 2013, 8:03 AM
  • Oct. 2, 2013, 12:05 AM
Company Description
Monsanto Co along with its subsidiaries provides agricultural products for farmers. Its seeds, biotechnology traits, herbicides and precision agriculture products provide farmers with solutions that improve productivity.